ZA201403942B - Tablet containing 1-cyclopropyl-8-(difluoromethoxy)-7-[(1r)-1-methyl-2, 3-dihydro-1h-isoindol-5-yl]-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid methanesulfonate hydrate - Google Patents
Tablet containing 1-cyclopropyl-8-(difluoromethoxy)-7-[(1r)-1-methyl-2, 3-dihydro-1h-isoindol-5-yl]-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid methanesulfonate hydrateInfo
- Publication number
- ZA201403942B ZA201403942B ZA2014/03942A ZA201403942A ZA201403942B ZA 201403942 B ZA201403942 B ZA 201403942B ZA 2014/03942 A ZA2014/03942 A ZA 2014/03942A ZA 201403942 A ZA201403942 A ZA 201403942A ZA 201403942 B ZA201403942 B ZA 201403942B
- Authority
- ZA
- South Africa
- Prior art keywords
- isoindol
- dihydroquinoline
- difluoromethoxy
- cyclopropyl
- dihydro
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011261727 | 2011-11-30 | ||
| PCT/JP2012/080887 WO2013081044A1 (en) | 2011-11-30 | 2012-11-29 | Tablet containing 1-cyclopropyl-8-(difluoromethoxy)-7-[(1r)-1-methyl-2, 3-dihydro-1h-isoindole-5-yl]-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid methanesulfonic acid hydrate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201403942B true ZA201403942B (en) | 2015-08-26 |
Family
ID=48535494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2014/03942A ZA201403942B (en) | 2011-11-30 | 2014-05-29 | Tablet containing 1-cyclopropyl-8-(difluoromethoxy)-7-[(1r)-1-methyl-2, 3-dihydro-1h-isoindol-5-yl]-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid methanesulfonate hydrate |
Country Status (10)
| Country | Link |
|---|---|
| JP (1) | JP6117112B2 (en) |
| CN (2) | CN104039322A (en) |
| BR (1) | BR112014012994A2 (en) |
| MX (1) | MX350659B (en) |
| MY (1) | MY169750A (en) |
| PH (1) | PH12014501224A1 (en) |
| RU (1) | RU2633477C2 (en) |
| SG (1) | SG11201402597WA (en) |
| WO (1) | WO2013081044A1 (en) |
| ZA (1) | ZA201403942B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017073738A1 (en) * | 2015-10-29 | 2017-05-04 | 日本臓器製薬株式会社 | Tablet having fexofenadine as effective component thereof |
| TWI727036B (en) * | 2016-04-27 | 2021-05-11 | 日商富山化學工業股份有限公司 | Tablet comprising tosufloxacin tosilate, disintegrant and acidic amino acid |
| JP7058104B2 (en) * | 2017-10-19 | 2022-04-21 | 日本化薬株式会社 | Pharmaceutical tablets containing aprepitant as an active ingredient |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4639458A (en) * | 1985-01-22 | 1987-01-27 | Merck & Co., Inc. | Tablet and formulation |
| EE04418B1 (en) * | 1998-11-10 | 2005-02-15 | Bayer Aktiengesellschaft | Pharmaceutical preparation of moxifloxacin |
| JP4370050B2 (en) * | 2000-12-04 | 2009-11-25 | 大正製薬株式会社 | Clarithromycin tablets and method for producing the same |
| ATE382338T1 (en) * | 2003-03-19 | 2008-01-15 | Jordanian Pharmaceutical Mfg | NON-HYGROSCOPIC PHARMACEUTICAL COMPOSITIONS CONTAINING NON-HYDRATED QUINOLONE CARBONIC ACID |
| JP4702763B2 (en) * | 2003-07-30 | 2011-06-15 | 塩野義製薬株式会社 | Stable tablets containing crystalline cellulose |
| CA2576589C (en) * | 2004-08-13 | 2013-11-12 | Schering-Plough Ltd. | Pharmaceutical formulation comprising an antibiotic, a triazole and a corticosteroid |
| US20070249577A1 (en) * | 2005-05-10 | 2007-10-25 | Hopkins Scott J | Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures |
| FI20080352A0 (en) * | 2008-05-09 | 2008-05-09 | Atacama Labs Oy | Process for preparing a tablet with high drug content |
| FI20080353A0 (en) * | 2008-05-09 | 2008-05-09 | Atacama Labs Oy | Process for preparing a tablet with extra high drug content |
| JP2011068647A (en) * | 2009-08-31 | 2011-04-07 | Kowa Co | Solid formulation containing aspartic acid or salt thereof |
| WO2011059075A1 (en) * | 2009-11-13 | 2011-05-19 | 味の素株式会社 | Glutamic acid-rich and arginine-rich preparation |
-
2012
- 2012-11-29 MX MX2014006378A patent/MX350659B/en active IP Right Grant
- 2012-11-29 WO PCT/JP2012/080887 patent/WO2013081044A1/en active Application Filing
- 2012-11-29 JP JP2013547208A patent/JP6117112B2/en active Active
- 2012-11-29 MY MYPI2014701375A patent/MY169750A/en unknown
- 2012-11-29 BR BR112014012994A patent/BR112014012994A2/en not_active Application Discontinuation
- 2012-11-29 CN CN201280066321.0A patent/CN104039322A/en active Pending
- 2012-11-29 CN CN201910108608.9A patent/CN109662952A/en active Pending
- 2012-11-29 RU RU2014126094A patent/RU2633477C2/en active
- 2012-11-29 SG SG11201402597WA patent/SG11201402597WA/en unknown
-
2014
- 2014-05-29 ZA ZA2014/03942A patent/ZA201403942B/en unknown
- 2014-05-30 PH PH12014501224A patent/PH12014501224A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MY169750A (en) | 2019-05-15 |
| CN104039322A (en) | 2014-09-10 |
| WO2013081044A1 (en) | 2013-06-06 |
| SG11201402597WA (en) | 2014-09-26 |
| CN109662952A (en) | 2019-04-23 |
| BR112014012994A2 (en) | 2017-06-13 |
| MX2014006378A (en) | 2014-10-13 |
| PH12014501224B1 (en) | 2014-09-08 |
| RU2014126094A (en) | 2016-01-27 |
| PH12014501224A1 (en) | 2014-09-08 |
| MX350659B (en) | 2017-09-13 |
| JPWO2013081044A1 (en) | 2015-04-27 |
| RU2633477C2 (en) | 2017-10-12 |
| JP6117112B2 (en) | 2017-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1187259A1 (en) | Substituted quinoline compounds | |
| ZA201406639B (en) | Stabilized hypohalous acid solutions | |
| ZA201306072B (en) | Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds | |
| HK1201660A1 (en) | Automatic commercial playback system | |
| EP2799437A4 (en) | Quinoline and cinnoline compounds and use thereof | |
| IL236218A (en) | Dimethyl-benzoic acid compounds | |
| EP2916754A4 (en) | Polyaxial cross connector | |
| HK1210613A1 (en) | Process for the preparation of 4-amino-5-fluoro-3-halo-6- (substituted)picolinates 4--5--3--6-()-2- | |
| IL235802A0 (en) | New process for the preparation of 2-cyclopentyl-6-methoxy-isonicotinic acid | |
| SG11201505173RA (en) | Dicaffeoylquinic acid-containing drink | |
| ZA201504166B (en) | Process for the preparation of 4-amino-5-fluoro-3-chloro-6-(substituted)picolinates | |
| HK1200796A1 (en) | Header system | |
| ZA201403942B (en) | Tablet containing 1-cyclopropyl-8-(difluoromethoxy)-7-[(1r)-1-methyl-2, 3-dihydro-1h-isoindol-5-yl]-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid methanesulfonate hydrate | |
| IL239328A0 (en) | Continuous process for the preparation of (s)-2- acetyloxypropionic acid chloride | |
| ZA201504165B (en) | Process for the preparation of 4-amino-5-fluoro-3-chloro-6-(substituted)picolinates | |
| HK1180321A1 (en) | 1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-1,4- dihydro-3-quinolinecarboxylic acid salts 1--8--7-[5--6-()-3-]-4--14--3- | |
| TWM432435U (en) | Quick connector for fire fighting | |
| HK1189892A1 (en) | Novel method for synthesising ivabradine and its pharmaceutically acceptable acid addition salts | |
| AU5520P (en) | DrisStrawThirtyOne Fragaria x ananassa | |
| AU5522P (en) | DrisStrawTwentyEight Fragaria x ananassa | |
| ZA201306884B (en) | Stabilized hypohalous acid solutions | |
| AU5322P (en) | DrisStrawSixteen Fragaria x ananassa | |
| GB201105988D0 (en) | Acid formation | |
| AU2012900017A0 (en) | Processes for preparing 8-hydroxy quinoline derivatives |